The purpose of a clinical trial is to determine the most effective and safest treatment for a disease. Clinical trial evaluation is a key step to translating research into new medicines that can provide better outcomes for patients. The performance of clinical trials is a vital component of U.S. Food and Drug Administration’s drug approval process, without which advances in therapeutics for brain tumor patients would not be possible. Often the lengthiest aspect of the drug approval process is finding people to participate in trials. The NBTS Clinical Trial Finder is intended to help raise awareness and increase participation in clinical trials to facilitate brain tumor research and accelerate the development of new drugs and treatments for patients.
Today, an estimated 700,000 people in the United States are living with a primary brain tumor, and over 79,000 more will be diagnosed in 2017. Brain tumors can be deadly, significantly impact quality of life, and change everything for a patient and their loved ones. They do not discriminate, inflicting men, women, and children of all races and ethnicities.
Together, we are more powerful than brain tumors. Arm yourself with facts about symptoms, treatments, and clinical trials, and access helpful resources and tools for patients and caregivers.
Learn about our integrated programs in research, public policy and advocacy, read event highlights, and stay informed about other news relevant to the brain tumor community.